When to consider von Willebrand disease (Module 1 of 3)
When to consider von Willebrand disease (Module 1 of 3)
In this micro e-learning module you will learn about the potential existence of von Willebrand disease among your patient population and be able to recognise the signs and symptoms of von Willebrand disease
In this micro e-learning module you will learn about the potential existence of von Willebrand disease among your patient population and be able to recognise the signs and symptoms of von Willebrand disease
Dr. Vickie McDonald, Dr. Rosa Sonja Alesci, Assoc. Prof. Alison Dougall, Assoc. Prof. Michael A Mazzeffi, Prof. Jan Blatný, Prof. Ana Boban, Dr. Gianluigi Pasta, Dr. Jonathan C. Roberts
Watch the short video, download the flashcard and slides, and take the assessment to check your knowledge
Dr. Vickie McDonald
Haematologist
Royal London Hospital and Queen Mary University of London
United Kingdom (UK)
Dr. Rosa Sonja Alesci
Haematologist and Health Economist
IMD Blood Coagulation Centre
Germany
Assoc. Prof. Alison Dougall
Dental Consultant
Dublin Dental Hospital and Trinity College Dublin
Republic of Ireland
Assoc. Prof. Michael A Mazzeffi
Cardiothoracic Anesthesiologist and Intensive Care Physician
George Washington University School of Medicine
United States (US)
Prof. Jan Blatný
Paediatric Haematologist
Children's University Hospital Brno
Czech Republic
Prof. Ana Boban
Haematologist
University Hospital Centre Zagreb
Croatia
Dr. Gianluigi Pasta
Orthopedic Consultant
Hemophilia Centre at Fondazione IRCCS Policlinico San Matteo di P...
Italy
Dr. Jonathan C. Roberts
Paediatric and Adult Haematologist
Bleeding & Clotting Disorders Institute (BCDI)
United States (US)
| 
20 min
|accreditation:
EACCME |
May 2022
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
This micro e-learning programme consists of three modules aiming to increase awareness, knowledge and understanding of the existence, diagnosis, treatment and implications of von Willebrand disease among healthcare professionals outside of haematology.
Upon completion of the three modules, you will:
-
be aware of the potential existence of von Willebrand disease in your patient population
-
be able to recognise the signs and symptoms of von Willebrand disease
-
understand how to search for von Willebrand disease, effectively using the screening tools available and signposting patients towards earlier diagnosis
-
be aware of the impact of von Willebrand disease on other care
This micro e-learning is endorsed by:
HEMOSTASIS CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Takeda.
Other programmes of interest
60 min
Other programmes developed by Dr. Vickie McDonald
Dr. Vickie McDonald
Haematologist
Royal London Hospital and Queen Mary University of London
United Kingdom (UK)
Other programmes developed by Dr. Rosa Sonja Alesci
Dr. Rosa Sonja Alesci
Haematologist and Health Economist
IMD Blood Coagulation Centre
Germany
Other programmes developed by Assoc. Prof. Alison Dougall
Assoc. Prof. Alison Dougall
Dental Consultant
Dublin Dental Hospital and Trinity College Dublin
Republic of Ireland
Other programmes developed by Assoc. Prof. Michael A Mazzeffi
Assoc. Prof. Michael A Mazzeffi
Cardiothoracic Anesthesiologist and Intensive Care Physician
George Washington University School of Medicine
United States (US)
Other programmes developed by Prof. Jan Blatný
Prof. Jan Blatný
Paediatric Haematologist
Children's University Hospital Brno
Czech Republic
Other programmes developed by Prof. Ana Boban
Prof. Ana Boban
Haematologist
University Hospital Centre Zagreb
Croatia
Other programmes developed by Dr. Gianluigi Pasta
Dr. Gianluigi Pasta
Orthopedic Consultant
Hemophilia Centre at Fondazione IRCCS Policlinico San Matteo di P...
Italy
Other programmes developed by Dr. Jonathan C. Roberts
Dr. Jonathan C. Roberts
Paediatric and Adult Haematologist
Bleeding & Clotting Disorders Institute (BCDI)
United States (US)